These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 7923439

  • 1. The interaction of glutathione with 4-hydroxycyclophosphamide and phosphoramide mustard, studied by 31P nuclear magnetic resonance spectroscopy.
    Dirven HA, Venekamp JC, van Ommen B, van Bladeren PJ.
    Chem Biol Interact; 1994 Dec; 93(3):185-96. PubMed ID: 7923439
    [Abstract] [Full Text] [Related]

  • 2. Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione.
    Dirven HA, van Ommen B, van Bladeren PJ.
    Cancer Res; 1994 Dec 01; 54(23):6215-20. PubMed ID: 7954469
    [Abstract] [Full Text] [Related]

  • 3. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.
    Low JE, Borch RF, Sladek NE.
    Cancer Res; 1982 Mar 01; 42(3):830-7. PubMed ID: 7059981
    [Abstract] [Full Text] [Related]

  • 4. NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. A comprehensive kinetic analysis of the interconversion of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and the concomitant partitioning of aldophosphamide between irreversible fragmentation and reversible conjugation pathways.
    Zon G, Ludeman SM, Brandt JA, Boyd VL, Ozkan G, Egan W, Shao KL.
    J Med Chem; 1984 Apr 01; 27(4):466-85. PubMed ID: 6708049
    [Abstract] [Full Text] [Related]

  • 5. Half-life of oxazaphosphorines in biological fluids.
    Sladek NE, Powers JF, Grage GM.
    Drug Metab Dispos; 1984 Apr 01; 12(5):553-9. PubMed ID: 6149904
    [Abstract] [Full Text] [Related]

  • 6. Glutathione conjugation of the cytostatic drug ifosfamide and the role of human glutathione S-transferases.
    Dirven HA, Megens L, Oudshoorn MJ, Dingemanse MA, van Ommen B, van Bladeren PJ.
    Chem Res Toxicol; 1995 Apr 01; 8(7):979-86. PubMed ID: 8555414
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of 4-hydroxycyclophosphamide and metabolites in the rat.
    Hong PS, Srigritsanapol A, Chan KK.
    Drug Metab Dispos; 1991 Apr 01; 19(1):1-7. PubMed ID: 1673381
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quantitation of 4-hydroxycyclophosphamide/aldophosphamide in whole blood.
    Anderson LW, Ludeman SM, Colvin OM, Grochow LB, Strong JM.
    J Chromatogr B Biomed Appl; 1995 May 19; 667(2):247-57. PubMed ID: 7663697
    [Abstract] [Full Text] [Related]

  • 10. Glutathione conjugation with phosphoramide mustard and cyclophosphamide. A mechanistic study using tandem mass spectrometry.
    Yuan ZM, Smith PB, Brundrett RB, Colvin M, Fenselau C.
    Drug Metab Dispos; 1991 May 19; 19(3):625-9. PubMed ID: 1680629
    [Abstract] [Full Text] [Related]

  • 11. Accelerated decomposition of 4-hydroxycyclophosphamide by human serum albumin.
    Kwon CH, Maddison K, LoCastro L, Borch RF.
    Cancer Res; 1987 Mar 15; 47(6):1505-8. PubMed ID: 3815352
    [Abstract] [Full Text] [Related]

  • 12. Plasma concentrations of 4-hydroxycyclophosphamide and phosphoramide mustard in patients repeatedly given high doses of cyclophosphamide in preparation for bone marrow transplantation.
    Sladek NE, Doeden D, Powers JF, Krivit W.
    Cancer Treat Rep; 1984 Oct 15; 68(10):1247-54. PubMed ID: 6395951
    [Abstract] [Full Text] [Related]

  • 13. Direct detection of the intracellular formation of carboxyphosphamides using nuclear magnetic resonance spectroscopy.
    Boal JH, Ludeman SM, Ho CK, Engel J, Niemeyer U.
    Arzneimittelforschung; 1994 Jan 15; 44(1):84-93. PubMed ID: 8135883
    [Abstract] [Full Text] [Related]

  • 14. The partitioning of phosphoramide mustard and its aziridinium ions among alkylation and P-N bond hydrolysis reactions.
    Shulman-Roskes EM, Noe DA, Gamcsik MP, Marlow AL, Hilton J, Hausheer FH, Colvin OM, Ludeman SM.
    J Med Chem; 1998 Feb 12; 41(4):515-29. PubMed ID: 9484502
    [Abstract] [Full Text] [Related]

  • 15. O-Methylhydroxylamine as a new trapping reagent for quantitative studies of 4-hydroxycyclophosphamide and aldophosphamide.
    Zon G, Ludeman SM, Sweet EM, Egan W, Phillips LR.
    J Pharm Sci; 1982 Apr 12; 71(4):443-6. PubMed ID: 7086655
    [Abstract] [Full Text] [Related]

  • 16. Causes and possibilities to circumvent cyclophosphamide toxicity.
    Voelcker G.
    Anticancer Drugs; 2020 Jul 12; 31(6):617-622. PubMed ID: 32044797
    [Abstract] [Full Text] [Related]

  • 17. In situ preparation and fate of cis-4-hydroxycyclophosphamide and aldophosphamide: 1H and 31P NMR evidence for equilibration of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and its hydrate in aqueous solution.
    Borch RF, Hoye TR, Swanson TA.
    J Med Chem; 1984 Apr 12; 27(4):490-4. PubMed ID: 6708051
    [Abstract] [Full Text] [Related]

  • 18. Binding of metabolites of cyclophosphamide to DNA in a rat liver microsomal system and in vivo in mice.
    Hemminki K.
    Cancer Res; 1985 Sep 12; 45(9):4237-43. PubMed ID: 4028012
    [Abstract] [Full Text] [Related]

  • 19. Effect of stereochemistry on the oxidative metabolism of the cyclophosphamide metabolite aldophosphamide.
    Habib AD, Boal JH, Hilton J, Nguyen T, Chang YH, Ludeman SM.
    Biochem Pharmacol; 1995 Jul 31; 50(3):429-33. PubMed ID: 7646546
    [Abstract] [Full Text] [Related]

  • 20. Population pharmacokinetics of cyclophosphamide and its metabolites 4-hydroxycyclophosphamide, 2-dechloroethylcyclophosphamide, and phosphoramide mustard in a high-dose combination with Thiotepa and Carboplatin.
    de Jonge ME, Huitema AD, van Dam SM, Rodenhuis S, Beijnen JH.
    Ther Drug Monit; 2005 Dec 31; 27(6):756-65. PubMed ID: 16306851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.